Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
China Quetiapine Market Investigation Report 2010-2019 | ||
By: PR Newswire Association LLC. - 28 Aug 2015 | Back to overview list |
|
DUBLIN, Aug. 28, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/z3rtg7/investigation) has announced the addition of the "Investigation Report on China's Quetiapine Market, 2010-2019" report to their offering. Developed by AstraZeneca plc, quetiapine (under the trade name of Seroquel) is an important drug for the treatment of schizophrenia. Approved by CFDA to treat schizophrenia in 2000, quetiapine was listed in the Catalogue of Drugs for the Basic National Medical Insurance in 2014. Currently, local manufacturers of quetiapine are Hunan Dongting Pharmaceutical Co., Ltd and Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory, the former owning relevant patent for quetiapine compound according to CFDA. Key Topics Covered: Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net SOURCE Research and Markets |
||
|
||
Copyright 2015 PR Newswire Association LLC. | Back to overview list |